http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6330495-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03986c8fac9a9ef6d93eb131b664d954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_543c6c65952993acf92ccbb172d070c4
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06
filingDate 1986-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d8dfffb5b78c12f8b529f9a847d9dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71068ba7653baf95a8dd82eb4754118a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c15963aa56cdaba0cf46930ace7f7e
publicationDate 1988-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6330495-A
titleOfInvention Steric isomer of lipid a monosaccharide analog
abstract NEW MATERIAL:A compound shown by formula I (one of R 1 and R 2 is H and the other is lauric acid residue or palmitic acid residue; asymmetric carbon atoms indicated with * are both rectus type isomers or both sinister type isomers or one of the asymmetric carbon atoms is rectus type isomer). n EXAMPLE: 2-Deoxy-3-[ ( 3R )-O-( 3-hydroxytetradecanoyl )-4-O-phosphoryl-2-[ (3R)-tetradecanoyl )-tetradecanoylamino ]-D-glucopyranose. n USE: An antitumor agent. n PREPARATION: For example, 2-amino-deoxy-4,6-O-isopropylidene-β-D- glucopyranoside is reacted with (3R)-3-tetradecanoyloxytetradecanoic acid in a solvent in the presence of a condensation agent, isopropylidene group is removed, diphenylphosphono group is introduced to the 4-position and further dediphenylation is carried out to give a compound shown by the formula. n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7966737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010090139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9104259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5278300-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5191072-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7146737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5598870-A
priorityDate 1986-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228184884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235887775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422165728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70405334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455904803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410314

Total number of triples: 38.